# Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients

Study · id `cardio:ct-nct04083690` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04083690](<https://clinicaltrials.gov/study/NCT04083690>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04083690

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04083690. Randomized; double masking; primary purpose treatment. Start 2019-10-11 (actual); primary completion 2023-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04083690, source copy `cardio:ctgov-nct04083690-2022-06-09`, retrieved 2026-10-26)
- Started: 2019-10-11 (actual) (ClinicalTrials.gov record NCT04083690, source copy `cardio:ctgov-nct04083690-2022-06-09`, retrieved 2026-10-26)
- Primary completion: 2023-10-01 (anticipated) (ClinicalTrials.gov record NCT04083690, source copy `cardio:ctgov-nct04083690-2022-06-09`, retrieved 2026-10-26)
- Completion: 2024-10-01 (anticipated) (ClinicalTrials.gov record NCT04083690, source copy `cardio:ctgov-nct04083690-2022-06-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04083690, source copy `cardio:ctgov-nct04083690-2022-06-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04083690-2022-06-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients
- Acronym: METEOR-CRT
- Condition: Heart Failure, Systolic
- Intervention (Device): Reprogramming of CRT Device Settings to Optimal Electrical Synchrony
- Lead sponsor: Allina Health System
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry lists this organization as the lead sponsor: Allina Health System (`cardio:org-allina-health-system`)

## Provenance

Content hash: 5cdae114862333a1b9e9e3dfb6f18873f4c02c12ce139ea80014af1ca74dcf37
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
